Jasna Hocevar-Trnka, MD, MPH

home / authors / jasna-hocevar-trnka-md-mph

Articles

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression

Robert Alexander, MD;Jasna Hocevar-Trnka, MD, MPH;Nathan Bryson, PhD;Beatrix Taylor, BSc, MSc

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

Latest Updated Articles

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: April 2nd 2025

Poor DSM-5—So Misunderstood!

Mini Quiz: Methods of Suicide

Published: January 21st 2016 | Updated: April 2nd 2025

Mini Quiz: Methods of Suicide

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: April 2nd 2025

Mini Quiz: Treatment for Pedophilia?

Mini Quiz: Suicide Risk in Veterans

Published: July 18th 2016 | Updated: April 2nd 2025

Mini Quiz: Suicide Risk in Veterans

smoking

Published: March 27th 2025 | Updated: April 2nd 2025

In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function

emotion cognition

Published: March 25th 2025 | Updated: April 2nd 2025

Emotion and Cognitive Control: An Essential Partnership for Adaptive Behavior

Recent Content

FDA

New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia

foolish

Standing Up Against Hate: Let’s Be Foolish

April Theme: Sleep

Presenting Our April Theme: Sleep

pills

The Psychiatric Pipeline in Review: Quarter 1, 2025

View More Recent Content

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.